Indications and Considerations for PTFE Grafts in Vascular Surgery
PTFE (polytetrafluoroethylene) grafts should be used as the second-line option for vascular access after arteriovenous fistulas have been ruled out or have failed, particularly in hemodialysis patients who need reliable vascular access. 1
Primary Indications for PTFE Grafts
When native arteriovenous fistulas cannot be established due to:
- Inadequate vessel quality or size
- Failed previous fistula attempts
- Need for more immediate access (compared to fistula maturation time)
- As a "planned bridge" to a future fistula 1
Specific clinical scenarios where PTFE grafts are preferred:
- Patients requiring rapid access for hemodialysis (PTFE grafts mature faster)
- Patients with poor peripheral vessels unsuitable for fistula creation
- Patients with limited life expectancy where fistula maturation time is impractical
- When previous fistula attempts have failed 1
Advantages of PTFE Grafts
- Large surface area available for cannulation
- Technically easier to cannulate compared to fistulas
- Shorter maturation time (14 days minimum, ideally 3-6 weeks)
- Multiple insertion sites available
- Variety of shapes and configurations for placement flexibility
- Easier surgical handling and anastomosis construction
- Comparatively easier to repair surgically or endovascularly 1
Placement Considerations
Preferred configurations:
- Antecubital loop graft
- Upper-arm curved graft 1
Arterial inflow sites options:
- Radial artery at the wrist
- Brachial artery in the antecubital fossa
- Brachial artery in lower portion of arm
- Brachial artery below axilla
- Axillary artery
- Femoral artery (less preferred due to infection risk) 1
Venous outflow site options:
- Median antecubital vein
- Proximal and distal cephalic vein
- Basilic vein at elbow level
- Basilic vein at upper arm level
- Axillary vein
- Jugular vein
- Femoral vein 1
Material Selection and Modifications
Standard wall 6-mm PTFE remains the gold standard for vascular grafts 1
No convincing evidence supports one PTFE modification over another:
- Tapered vs. uniform tubes
- Externally supported vs. unsupported grafts
- Thick vs. thin-walled configurations
- Elastic vs. nonelastic material 1
Early cannulation grafts (composite/PU grafts) may be considered as a catheter-sparing strategy 1
Important Clinical Considerations
Expected lifespan: PTFE grafts typically last 3-5 years 1
Maturation time: Minimum 14 days before cannulation, ideally 3-6 weeks to allow for tissue incorporation 1
Vessel preservation strategy: Consider using smaller, more peripheral vessels for graft placement to preserve proximal sites for future access creation, despite potentially higher thrombosis risk 1
Avoid proximal vessel temptation: Resist using larger proximal vessels despite better initial flow and patency, as this limits future access options 1
Infection risk: PTFE has lower risk of disintegration with infection compared to biological grafts 1
Thrombosis risk: Most common complication with PTFE grafts; requires careful monitoring and prompt intervention 2
Common Pitfalls to Avoid
- Placing grafts in proximal vessels first, which limits future access options
- Cannulating too early (before 14 days), increasing risk of complications
- Neglecting regular surveillance for stenosis or thrombosis
- Failing to consider PTFE grafts as a "bridge" to future fistula creation
- Using femoral placement without careful consideration of potential complications for future kidney transplantation 1
Monitoring and Complications
- Regular surveillance is essential to detect dysfunction before thrombosis
- Most common complications include:
By following these guidelines for PTFE graft placement and management, vascular access can be optimized to support effective hemodialysis while preserving future access options.